Generate a tailored SOP for Dr. Mario Monteiro. Improve your application with a focused, well-structured draft.
Prof. Mario Monteiro, a Full Professor at the University of Guelph since 2003, specializes in polysaccharide chemistry with a focus on carbohydrate-based vaccines. His research addresses the growing threat of antibiotic resistance and aims to develop innovative vaccines to combat serious bacterial diseases. Key projects include evaluating polysaccharide vaccines for colorectal cancer pathogens, specifically investigating Fusobacterium nucleatum. Monteiro's team discovered the polysaccharide structure on this bacterium's surface, providing insights into disease mechanisms and potential vaccine applications. Furthermore, they have developed a vaccine for Traveler’s Diarrhea targeting Campylobacter jejuni, which proved effective in mice and nonhuman primates. Prof. Monteiro is also exploring vaccines against Clostridioides difficile, targeting the carbohydrate components of the bacterium's surface, and is working on a vaccine to combat autism-associated gut bacteria, particularly Clostridium bolteae. His research efforts extend to the development of a vaccine for Alloiococcus otitidis, linked to middle ear infections in children. Monteiro has served on the Editorial Review Board for Vaccines since 2017 and has received several awards for his contributions to the field of vaccine development.
Canadian Bacterial Diseases Network •
National Research Council •
Wyeth Pharmaceuticals •
University of Guelph • Guelph, ON, Canada
Teaching and conducting research in polysaccharide chemistry and vaccine development.
Department of Clinical Studies. Offers MSc by thesis (2 years) and MSc by coursework (1 year).